Strata Skin Sciences Gross Margin 2011-2025 | SSKN
Current and historical gross margin for Strata Skin Sciences (SSKN) over the last 10 years. The current gross profit margin for Strata Skin Sciences as of June 30, 2025 is %.
| Strata Skin Sciences Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.03B | $0.02B | 55.88% |
| 2025-03-31 | $0.03B | $0.02B | 58.82% |
| 2024-12-31 | $0.03B | $0.02B | 55.88% |
| 2024-09-30 | $0.03B | $0.02B | 54.55% |
| 2024-06-30 | $0.03B | $0.02B | 54.55% |
| 2024-03-31 | $0.03B | $0.02B | 51.52% |
| 2023-12-31 | $0.03B | $0.02B | 52.94% |
| 2023-09-30 | $0.04B | $0.02B | 55.56% |
| 2023-06-30 | $0.04B | $0.02B | 58.33% |
| 2023-03-31 | $0.04B | $0.02B | 59.46% |
| 2022-12-31 | $0.04B | $0.02B | 61.11% |
| 2022-09-30 | $0.03B | $0.02B | 61.76% |
| 2022-06-30 | $0.03B | $0.02B | 60.61% |
| 2022-03-31 | $0.03B | $0.02B | 64.52% |
| 2021-12-31 | $0.03B | $0.02B | 66.67% |
| 2021-09-30 | $0.03B | $0.02B | 67.86% |
| 2021-06-30 | $0.03B | $0.02B | 65.38% |
| 2021-03-31 | $0.02B | $0.01B | 60.87% |
| 2020-12-31 | $0.02B | $0.01B | 58.33% |
| 2020-09-30 | $0.03B | $0.02B | 57.69% |
| 2020-06-30 | $0.03B | $0.02B | 62.96% |
| 2020-03-31 | $0.03B | $0.02B | 64.52% |
| 2019-12-31 | $0.03B | $0.02B | 67.74% |
| 2019-09-30 | $0.03B | $0.02B | 66.67% |
| 2019-06-30 | $0.03B | $0.02B | 64.52% |
| 2019-03-31 | $0.03B | $0.02B | 63.33% |
| 2018-12-31 | $0.03B | $0.02B | 56.67% |
| 2018-09-30 | $0.03B | $0.02B | 54.84% |
| 2018-06-30 | $0.03B | $0.02B | 53.33% |
| 2018-03-31 | $0.03B | $0.02B | 54.84% |
| 2017-12-31 | $0.03B | $0.02B | 58.06% |
| 2017-09-30 | $0.03B | $0.02B | 60.00% |
| 2017-06-30 | $0.03B | $0.02B | 61.29% |
| 2017-03-31 | $0.03B | $0.02B | 61.29% |
| 2016-12-31 | $0.03B | $0.02B | 59.38% |
| 2016-09-30 | $0.03B | $0.02B | 60.61% |
| 2016-06-30 | $0.03B | $0.02B | 60.61% |
| 2016-03-31 | $0.03B | $0.01B | 34.62% |
| 2015-12-31 | $0.02B | $0.00B | 22.22% |
| 2015-09-30 | $0.01B | $0.00B | -33.33% |
| 2015-06-30 | $0.00B | $-0.01B | -900.00% |
| 2015-03-31 | $0.00B | $0.00B | 0.00% |
| 2014-12-31 | $0.00B | $0.00B | 0.00% |
| 2014-09-30 | $0.00B | $0.00B | 0.00% |
| 2014-06-30 | $0.00B | $-0.01B | 0.00% |
| 2014-03-31 | $0.00B | $-0.01B | 0.00% |
| 2013-12-31 | $0.00B | $-0.01B | 0.00% |
| 2013-09-30 | $0.00B | $-0.01B | 0.00% |
| 2013-06-30 | $0.00B | $0.00B | 0.00% |
| 2013-03-31 | $0.00B | $0.00B | 0.00% |
| 2012-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |